Valuation: ZIM Laboratories Limited

Market Cap 6.59B 69.18M 60.47M 55.58M 51.8M 98.25M 99.74M 667M 259M 3.24B 260M 254M 11.16B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.45B 78.24M 68.4M 62.86M 58.59M 111M 113M 755M 293M 3.66B 294M 287M 12.62B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.65%
Yield 2025 *
-
Yield 2026 -
1 day-0.08%
1 week-0.69%
Current month-1.05%
1 month+17.70%
3 months+84.49%
6 months+75.34%
Current year+71.09%
1 week 122.5
Extreme 122.5
126
1 month 103.45
Extreme 103.45
133.95
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.08%-0.69%+11.11%+14.47% 69.18M
+1.81%+2.25%+13.63%+82.33% 48B
+2.12%+5.91%+71.67%+116.91% 36.89B
+0.15%+1.26%-3.64%+44.26% 12.37B
+3.71%+3.56%+13.95%+94.97% 11.95B
+0.39%+0.58%+32.90%+119.07% 9.01B
+0.66%-0.57%+19.74%+45.99% 7.2B
+0.93%+1.27%+54.95%-4.44% 7.05B
+9.99%+32.94%-15.50%+21.82% 6.58B
+0.68%+2.63%+20.79%+232.98% 6.55B
Average +2.05%+3.75%+21.96%+76.84% 14.57B
Weighted average by Cap. +2.07%+3.35%+29.39%+89.18%

Financials

2025 2026
Net sales 3.79B 39.82M 34.81M 31.99M 29.82M 56.56M 57.42M 384M 149M 1.86B 149M 146M 6.42B 3.74B 39.32M 34.38M 31.59M 29.45M 55.85M 56.7M 379M 147M 1.84B 148M 144M 6.34B
Net income 122M 1.28M 1.12M 1.03M 957K 1.81M 1.84M 12.32M 4.79M 59.8M 4.8M 4.69M 206M 58.38M 613K 536K 493K 459K 871K 884K 5.91M 2.3M 28.7M 2.3M 2.25M 98.89M
Net Debt 1.16B 12.16M 10.63M 9.77M 9.1M 17.27M 17.53M 117M 45.59M 569M 45.64M 44.66M 1.96B 863M 9.06M 7.92M 7.28M 6.79M 12.87M 13.07M 87.43M 33.99M 424M 34.02M 33.29M 1.46B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-07-03 ₹123.00 -0.08% 2,591
26-07-02 ₹123.10 -1.52% 3,718
26-07-01 ₹125.00 +0.56% 8,541
26-06-30 ₹124.30 -1.58% 6,726
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock